Transarterial chemoembolization and sorafenib in patients with intermediate-stage hepatocellular carcinoma: time to enter routine clinical practice? (Q48411584)

From Wikidata

Jump to navigation Jump to search

scientific article published on 13 August 2015

Language	Label	Description	Also known as
English	Transarterial chemoembolization and sorafenib in patients with intermediate-stage hepatocellular carcinoma: time to enter routine clinical practice?	scientific article published on 13 August 2015

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26270206%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

0 references

Transarterial chemoembolization and sorafenib in patients with intermediate-stage hepatocellular carcinoma: time to enter routine clinical practice? (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26270206%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Giuseppe Cabibbo

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26270206%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Giuseppe Cabibbo

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26270206%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26270206%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Irene Bargellini

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26270206%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

author name string

Michela Antonucci

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26270206%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Sara Marceglia

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26270206%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Valeria Mismas

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26270206%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

language of work or name

0 references

publication date

13 August 2015

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26270206%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Future Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26270206%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26270206%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26270206%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

2371-2373

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26270206%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.173

21 January 2018

Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials.

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.173

21 January 2018

Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.173

21 January 2018

Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: available evidence and expert opinion on the use of transarterial chemoembolization.

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.173

21 January 2018

Loco-regional treatment of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.173

21 January 2018

Natural history of untreatable hepatocellular carcinoma: A retrospective cohort study

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.173

21 January 2018

A meta-analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.173

21 January 2018

Transarterial chemoembolization and sorafenib in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.173

21 January 2018

Multimodal approaches to the treatment of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.173

21 January 2018

Transcatheter arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): the role of angiogenesis and invasiveness

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.173

21 January 2018

GIDEON (Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with sorafeNib): second interim analysis

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.173

21 January 2018

Combination therapy of sorafenib and TACE for unresectable HCC: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.173

21 January 2018

Is the efficacy of sorafenib treatment in patients with hepatocellular carcinoma affected by age?

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.173

21 January 2018

Long-term results of sorafenib in advanced-stage hepatocellular carcinoma: what can we learn from routine clinical practice?

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.173

21 January 2018

Field-practice study of sorafenib therapy for hepatocellular carcinoma: A prospective multicenter study in Italy

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.173

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48411584&oldid=1208715098"